🔎 Trials Near Me

Akèy › Kansè nan tete › Alaska

Etid klinik pou Kansè nan tete nan Alaska

8 etid pou Kansè nan tete ap chèche patisipan nan sit nan Alaska.

Vil nan Alaska

Tèks ofisyèl etid la (Anglè)

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

  • Alaska Oncology and Hematology LLC, Anchorage
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Anchorage Associates in Radiation Medicine, Anchorage
  • Alaska Breast Care and Surgery LLC, Anchorage
  • Alaska Oncology and Hematology LLC, Anchorage
  • ak 3 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Alaska Oncology and Hematology, Anchorage
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07174336

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Anchorage Associates in Radiation Medicine, Anchorage
  • Alaska Breast Care and Surgery LLC, Anchorage
  • Alaska Oncology and Hematology LLC, Anchorage
  • ak 4 plis
Ap rekriteFaz 3
Laj 18 a 60 · Fanm · Mizajou Sep 2, 2026 · NCT05879926

Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial

  • Alaska Native Medical Center (ANMC), Anchorage
Ap rekrite
Laj 21 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT06802172

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Fairbanks Memorial Hospital, Fairbanks
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

  • Katmai Oncology Group - Anchorage, Anchorage
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT06401421

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

  • Providence Alaska Medical Center, Anchorage
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2025 · NCT03053193

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.